ECSP972256A - NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES - Google Patents
NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASESInfo
- Publication number
- ECSP972256A ECSP972256A ECSP972256A ECSP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A
- Authority
- EC
- Ecuador
- Prior art keywords
- prophylaxis
- degenerative diseases
- pain
- diseases
- new treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000003412 degenerative effect Effects 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010003591 Ataxia Diseases 0.000 abstract 1
- 206010058019 Cancer Pain Diseases 0.000 abstract 1
- 206010008748 Chorea Diseases 0.000 abstract 1
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 abstract 1
- 208000026072 Motor neurone disease Diseases 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 208000012601 choreatic disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 208000005264 motor neuron disease Diseases 0.000 abstract 1
- 201000003631 narcolepsy Diseases 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000007971 neurological deficit Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
- 206010044652 trigeminal neuralgia Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados y análogos de benzopirano se describen como útiles para el tratamiento y/o la profilaxis de enfermedades degenerativas tales como corea de huntingdon, esquizofrenia, déficits neurológicos asociados con el SIDA, trastornos del sueño(incluidos trastornos del ritmo circadiano, insomnio y narcolepsia), tios por (ejemplo, síndrome de Giles de la Tourette), lesión traumática del cerebro, zumbido, neuralgia, especialmente neuralgia trigémina, dolor neuropático, dolor dental, dolor de cáncer, actividad neuronal inapropiada que resulta en una neurodistesia en enfermedades tales como diabetes, EM y la enfermedad de la neurona motora, ataxias, rigidez muscular (espasmos) y disfunción de la unión temporomandibular.Benzopyran derivatives and analogs are described as useful for the treatment and / or prophylaxis of degenerative diseases such as huntingdon's chorea, schizophrenia, neurological deficits associated with AIDS, sleep disorders (including circadian rhythm disorders, insomnia and narcolepsy), uncles for example (Giles de la Tourette syndrome), traumatic brain injury, tinnitus, neuralgia, especially trigeminal neuralgia, neuropathic pain, dental pain, cancer pain, inappropriate neuronal activity resulting in neurodystesia in diseases such as diabetes, MS and motor neuron disease, ataxias, muscle stiffness (spasms) and dysfunction of the temporomandibular junction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972256A true ECSP972256A (en) | 1998-11-30 |
Family
ID=42043087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972256A (en) |
-
1997
- 1997-09-15 EC ECSP972256 patent/ECSP972256A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2082887T3 (en) | FLUPIRTINE IN COMBINATION WITH ANTIPARKINSONIANS TO COMBAT MUSCULAR SPASMS. | |
| DK1303495T3 (en) | Substituted 5-alkylnylpyrimidines with neurotrophic activity | |
| IL225192A (en) | Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury | |
| DE60324449D1 (en) | INHIBITORS OF PHOSPHODIESTERASE OF CYCLIC N, AND THEIR USE IN THERAPY | |
| ATE381935T1 (en) | USE OF TRIACETYLURIDINE TO TREAT MITOCHONDRIAL DISEASES | |
| DE69827513D1 (en) | ARRANGEMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY INFUSION OF NERVOUS GROWTH FACTORS IN THE BRAIN | |
| EP0970720A3 (en) | Treatment of pain and the nervous system | |
| ES2188793T3 (en) | AGENT FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES. | |
| ATE209492T1 (en) | USE OF 1,2,4-TRIAZOLO(1,5-C)PYRIMIDINE HETEROCYCLIC ANALOGUE FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS | |
| EP1420854A4 (en) | Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation | |
| GT200000203A (en) | COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS. | |
| CR6620A (en) | AMINO BICYCLE ACIDS AS PHARMACEUTICAL AGENTS | |
| IL139591A0 (en) | Combination therapy for treatment of bipolar disorders | |
| AR008838A1 (en) | NEW TREATMENT. | |
| HN1999000146A (en) | PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS. | |
| TR200001471T2 (en) | Use of aminomethyl-chroma substitute for the prevention of nerve cell degeneration and regeneration of nerve cells. | |
| BR0009296A (en) | Pharmaceutical composition, processes to induce differentiation of neural cells from target cells, to promote neural activity in an individual, and to prevent or treat disorders and diseases that can be prevented by promoting neural cell differentiation and / or neural activity, and, use a compound | |
| ES2134709A1 (en) | Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness | |
| ID23528A (en) | THERAPEUTIC TREATMENT FOR SKIN DISORDERS | |
| ECSP972256A (en) | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES | |
| MXPA00010254A (en) | The treatment of sexual dysfunction in certain patient groups. | |
| BR9406034A (en) | Imidazoloquinoxalinone derivatives as eaa antagonists. | |
| RU94006635A (en) | Method for correcting functional state | |
| HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
| ATE512664T1 (en) | COMPOSITION CONTAINING SPHINGOMYELIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS |